Opus Genetics IRD
NASDAQ IRD
$3.47 -0.35 (-9.16%)
At close: Oct 23, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Purchase of Investments (2010 - 2019)

Updated

Analysis

Opus Genetics (IRD) Purchase of Investments (2010 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Opus Genetics 286.79 Mn 62.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 8.89 Mn
Dec 31, 2017 6.01 Mn
Jun 30, 2017 13.00 Mn
Mar 31, 2017 2.01 Mn
Sep 30, 2016 7.03 Mn
Mar 31, 2016 1.72 Mn
Dec 31, 2015 7.17 Mn
Mar 31, 2015 740,825.00
Dec 31, 2014 5.52 Mn
Jun 30, 2011 8.00 Mn
Dec 31, 2010 1.85 Mn
Sep 30, 2010 503,960.00
API Access

Opus Genetics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=IRD&period=max&api_key=YOUR_API_KEY